Amentum Holdings Q1 2026 – Revenue Down 5%, Operating Income Up 5%, Net Income Surges 67%

By Chris Stiles • Tuesday, February 10 03:12 • Permanent Link

Amentum Holdings, Inc. reported its first quarter fiscal year 2026 results, showing a 5% decrease in revenues from $3.416 billion in the previous period to $3.237 billion in the current period. Despite this, the company saw a 5% increase in operating income, rising from $132 million to $138 million. Net income also experienced a significant surge, jumping from $122 million to $44 million, marking a 67% change.

In terms of earnings per share, diluted earnings per share rose by 260%, increasing from $0.05 to $0.18. Adjusted diluted earnings per share also saw a 6% uptick, climbing from $0.51 to $0.54.

Furthermore, Amentum's adjusted EBITDA remained relatively stable at $263 million in the current period, compared to $262 million in the previous period, with an adjusted EBITDA margin of 18.1%, up by 40 basis points from 7.7%.

However, the company reported negative free cash flow of $142 million in the current period, compared to positive free cash flow of $102 million in the previous period, indicating a significant change.

Amentum also highlighted its backlog of $47.2 billion and a book-to-bill ratio of 1.0x, with the last twelve months' book-to-bill ratio standing at 1.1x. Moody's upgraded the company's credit rating to ba3 from ba1.

Following these announcements, the company's shares moved 0.64%, and are now trading at a price of $34.80. For the full picture, make sure to review Amentum's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.